Risk of New Vertebral Fracture and Combination Therapy with Zoledronic Acid and Teriparatide in Diabetic Patients after Percutaneous Kyphoplasty

STUDY DESIGN: This was a retrospective clinical study. PURPOSE: This study aimed to evaluate the effect of combination therapy with zoledronic acid and teriparatide on the risk of new vertebral fracture (NVF) in type 2 diabetes mellitus (T2DM) patients after percutaneous kyphoplasty (PKP). OVERVIEW...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Jian, Yan, Bin, Chen, Zhe, Zheng, Zhaomin, Yang, Changsheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Spine Surgery 2021
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8561158/
https://www.ncbi.nlm.nih.gov/pubmed/33189105
http://dx.doi.org/10.31616/asj.2020.0282

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8561158/
https://www.ncbi.nlm.nih.gov/pubmed/33189105
http://dx.doi.org/10.31616/asj.2020.0282

Ejemplares similares